Displaying drugs 12401 - 12425 of 12630 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Vitamin D | Not Available |  | An ingredient found in a variety of supplements and vitamins. | Bone Density Conservation Agents / Secosteroids / Vitamin D and Analogues / Vitamins |
| Vitamin E | 430.7061 C29H50O2 |  | An antioxidant vitamin used in many skin creams and multivitamin preparations. | Antioxidants / Benzopyrans / Vitamin E, analogs & derivatives / Vitamins |
| Vitamin K7 | 173.215 C11H11NO |  | Not Annotated | Not Annotated |
| Vitexin | 432.381 C21H20O10 |  | Not Annotated | Goiter |
| Vixotrigine | 314.36 C18H19FN2O2 |  | Vixotrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression. | Amino Acids / Amino Acids, Cyclic / Amino Acids, Peptides, and Proteins / Benzene Derivatives / Ethers / Imino Acids / Phenols |
| VK-0214 | 412.422 C23H25O5P |  | Not Annotated | Not Annotated |
| VK-2809 | 514.98 C28H32ClO5P |  | VK-2809 is under investigation in clinical trial NCT02927184 (Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease). | Organophosphorus Compounds |
| VL-2397 | 914.951 C40H59AlN10O13 |  | Not Annotated | Antifungal Agents |
| VLTS-589 | Not Available |  | Investigated for use/treatment in peripheral vascular disease. | Not Available |
| VLX-1005 | 441.52 C21H19N3O4S2 |  | Not Annotated | Amides / Benzene Derivatives / Sulfonamides / Sulfones / Sulfur Compounds |
| VLX-1570 | 469.401 C23H17F2N3O6 |  | VLX-1570 is under investigation in clinical trial NCT02372240 (A Study of VLX1570 and Dexamethasone in Myeloma Patients). | Benzene Derivatives |
| VM4-037 | 620.67 C26H29FN6O7S2 |  | VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037). | Fluorine Radioisotopes |
| VMD-928 | 524.621 C31H32N4O4 |  | Not Annotated | Not Annotated |
| Voacamine | 704.8968 C43H52N4O5 |  | For the treatment of malaria. Also under investigation for the modulation of multidrug resistance in cancer cells. | Alkaloids / Heterocyclic Compounds, Fused-Ring / Indole Alkaloids / Indoles / Indolizidines / Indolizines / P-glycoprotein inhibitors / Secologanin Tryptamine Alkaloids |
| Vocacapsaicin | 459.631 C26H41N3O4 |  | Not Available | Not Available |
| Voclosporin | 1214.646 C63H111N11O12 |  | A calcineurin inhibitor for the treatment of lupus nephritis (LN) in patients diagnosed with systemic lupus erythematosus (SLE). | Calcineurin Inhibitors |
| Vodobatinib | 453.93 C27H20ClN3O2 |  | Not Annotated | Not Annotated |
| Vodudeutentan | 643.822 C34H51N5O7 |  | Not Available | Not Available |
| Vofopitant | 432.451 C21H23F3N6O |  | Vofopitant has been used in trials studying the treatment of PTSD, Primary Insomnia, and Sleep Initiation and Maintenance Disorders. | Antiemetics / Neurokinin-1 Receptor Antagonists |
| Voglibose | 267.2762 C10H21NO7 |  | An alpha-glucosidase inhibitor indicated in the management of postprandial blood glucose in patients with type II diabetes. | Glycoside Hydrolase Inhibitors |
| Volasertib | 618.8126 C34H50N8O3 |  | Volasertib has been used in trials studying the treatment of Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and Leukemia, Monocytic, Acute, among others. | Antineoplastic Agents / Heterocyclic Compounds, Fused-Ring |
| Volinanserin | 373.468 C22H28FNO3 |  | Volinanserin is under investigation in clinical trial NCT00464243 (Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study). | Serotonin Receptor Antagonists |
| Volixibat | 805.96 C38H51N3O12S2 |  | Volixibat is an investigational drug that has not been approved for use in any conditions. | Lipid Regulating Agents |
| Vonoprazan | 345.39 C17H16FN3O2S |  | A potassium-competitive acid blocker used in the treatment of acid-related disorders and as an adjunct to Helicobacter pylori eradication. | Alimentary Tract and Metabolism / Amides / Cytochrome P-450 CYP2B6 Substrates / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Drugs for Acid Related Disorders / Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord) / Gastric Acid Lowering Agents / P-glycoprotein inhibitors / Potassium-competitive Acid Blockers / Sulfones / Sulfur Compounds |
| Vorapaxar | 492.5817 C29H33FN2O4 |  | A platelet aggregation inhibitor used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). | Platelet Aggregation Inhibitors Excl. Heparin |
Displaying drugs 12401 - 12425 of 12630 in total